We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$94.2M
AUM Growth
+$7.66M
Cap. Flow
-$164K
Cap. Flow %
-0.17%
Top 10 Hldgs %
41.69%
Holding
106
New
19
Increased
31
Reduced
29
Closed
25

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.36M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.19M
3
BABA icon
Alibaba
BABA
+$1.84M
4
CRM icon
Salesforce
CRM
+$1.69M
5
DIS icon
Walt Disney
DIS
+$1.65M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$1.9M
2
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$1.43M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$1.16M
4
AMZN icon
Amazon
AMZN
+$1.09M
5
LYV icon
Live Nation Entertainment
LYV
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 46.39%
2 Miscellaneous 23.92%
3 Technology 14.03%
4 Communication Services 6.74%
5 Consumer Discretionary 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$489B
$13.7M 14.49%
73,100
+48,800
+201% +$8.98M
AGN
2
DELISTED
Allergan plc
AGN
$4.78M 5.07%
28,517
+17,012
+148% +$2.36M
QCOM icon
3
CALL
Qualcomm
QCOM
$175B
$3.51M 3.73%
46,200
-54,100
-54% -$3.96M
BABA icon
4
Alibaba
BABA
$296B
$2.74M 2.91%
16,171
+10,651
+193% +$1.84M
HUM icon
5
Humana
HUM
$46.3B
$2.73M 2.9%
10,284
+2,997
+41% +$760K
CRM icon
6
Salesforce
CRM
$211B
$2.59M 2.75%
17,052
+10,809
+173% +$1.69M
ZBH icon
7
Zimmer Biomet
ZBH
$19.2B
$2.52M 2.68%
22,051
+2,450
+12% +$287K
AMGN icon
8
PUT
Amgen
AMGN
$234B
$2.51M 2.66%
+13,600
New +$2.44M
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$12.5B
$2.19M 2.33%
+25,610
New +$2.19M
WCG
10
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.05M 2.18%
7,199
+1,333
+23% +$368K
MCHP icon
11
Microchip Technology
MCHP
$39.6B
$1.94M 2.06%
44,712
-17,510
-28% -$778K
DIS icon
12
Walt Disney
DIS
$187B
$1.74M 1.84%
+12,429
New +$1.65M
PYPL icon
13
PayPal
PYPL
$45.9B
$1.72M 1.82%
15,009
-558
-4% -$61.8K
PGR icon
14
Progressive
PGR
$127B
$1.65M 1.75%
+20,617
New +$1.59M
GDDY icon
15
GoDaddy
GDDY
$12.4B
$1.64M 1.74%
23,385
-9,153
-28% -$690K
SYK icon
16
Stryker
SYK
$127B
$1.62M 1.72%
7,867
-3,740
-32% -$714K
INTU icon
17
Intuit
INTU
$97.9B
$1.61M 1.71%
6,163
-1,488
-19% -$378K
HCA icon
18
HCA Healthcare
HCA
$90.5B
$1.56M 1.66%
11,560
+5,824
+102% +$736K
IQV icon
19
IQVIA
IQV
$43.1B
$1.53M 1.63%
9,542
+5,193
+119% +$729K
GILD icon
20
Gilead Sciences
GILD
$181B
$1.43M 1.51%
+21,102
New +$1.39M
EW icon
21
Edwards Lifesciences
EW
$52B
$1.41M 1.49%
22,848
+2,697
+13% +$163K
MSFT icon
22
Microsoft
MSFT
$3.81T
$1.4M 1.49%
10,475
+1,497
+17% +$190K
PEN icon
23
Penumbra
PEN
$12.7B
$1.39M 1.47%
8,660
+516
+6% +$74.5K
TWTR
24
DELISTED
Twitter, Inc.
TWTR
$1.29M 1.37%
+37,074
New +$1.36M
ICUI icon
25
ICU Medical
ICUI
$4.38B
$1.26M 1.33%
4,990
-509
-9% -$118K
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Partner Investment Management held 106 positions worth $94.2M, up 8.9% from $86.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Partner Investment Management's Q2 2019 filing shows 19 new, 31 increased, 29 reduced and 25 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 25,610 shares worth $2.19M. The largest sale was UnitedHealth, an estimated $1.9M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Technology.

  • Partner Investment Management's largest Q2 2019 buy was BioMarin Pharmaceuticals: 25,610 shares worth $2.19M.
  • Partner Investment Management added most to Allergan plc in Q2 2019, an estimated $2.36M increase.
  • Partner Investment Management's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $1.9M.
  • Partner Investment Management fully exited Amazon in Q2 2019, selling an estimated $1.09M.
  • Partner Investment Management's ten largest holdings make up 42% of its $94.2M portfolio in Q2 2019.
  • Partner Investment Management opened 19 new positions and closed 25 in Q2 2019.
  • Partner Investment Management's portfolio value rose 8.9% quarter-over-quarter to $94.2M.

Based on Partner Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.